Press release
Fibrosarcoma Market Assessment by Products, Drug Profile forecast for 2017-2026
Fact.MR
Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=353
According to a study by Fact.MR, the global fibrosarcoma market is expected to witness steady growth. The market is likely to register CAGR of 5.5% during the forecast period 2017-2026. The global fibrosarcoma market is also projected to bring in US$ 442.4 million revenue. Fibrosarcoma is increasingly rare as a diagnosis compared to other sarcoma subtypes. Some of the sarcomas are sensitive to chemotherapy, hence ongoing attempts are being done to intensify chemotherapy. However, fibrosarcoma that does not respond to chemotherapy, needs to be treated with other methods but might lead to some side-effects. This is driving the development of new therapies with potential benefits. Below insights show how the global fibrosarcoma market will perform in the coming years.
Fibrosarcoma has no definite cause like other sarcomas. However, most of the sarcomas are associated with the genetic mutations. Soft tissue fibrosarcoma is among rare cancer which has no exact cause but carries various risk factors. Undergoing as radiotherapy to treat other cancer is one of the factors that is increasing the risk of fibrosarcoma. Currently, there are very few ways to treat fibrosarcoma with complications involved. Hence, researchers and research institutes around the world are researching for some very effective treatments. Targeted therapies are also being focused on to treat fibrosarcoma. There are also many anti-angiogenesis agents under development and few are in clinical trials. Chemotherapy for soft tissue sarcoma usually involves a combination of various drugs. Hence, companies are researching on new drugs effective in treating soft tissue sarcoma.
Browse Full Report with TOC- https://www.factmr.com/report/353/fibrosarcoma-market
5 Forecast Highlights on Global Fibrosarcoma Market
1. North America is expected to remain dominant in the global fibrosarcoma market during the forecast period 2017-2026. Well-developed healthcare infrastructure in North America is one of the factors boosting the growth of fibrosarcoma treatment in the region. Technological advancement is also resulting in the development of advanced cancer treatment drugs. Moreover, increasing population suffering from diabetes, overweight and depression are also leading towards high possibilities of cancer.
2. Europe and Asia Pacific Excluding Japan (APEJ) are also expected to witness growth in the diagnoses and treatment of fibrosarcoma due to the increasing investments in the research and development activities for treatment of various cancers.
3. Chemotherapy is expected to be the most preferred treatment for fibrosarcoma. By the end of 2026, chemotherapy is projected to reach close to US$ 200 million revenue.
4. Hospitals are expected to be the largest end-users in the global fibrosarcoma market. Hospitals are projected to reach nearly US$ 200 million revenue by the end of 2026.
5. Among various distribution channels, hospital pharmacy is expected to emerge as the largest distribution channel during the forecast period 2017-2026. Accounting for nearly half of the revenue share, hospital pharmacies are projected to exceed US$ 100 million revenue towards the end of 2026.
The report also offers an in-depth analysis of the leading market players in the global market for fibrosarcoma, which will remain active through 2026. These include companies such as Johnson & Johnson, Pfizer Inc., Eli Lilly and Company, Baxter International Inc., Novartis AG, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Bristol-Myers Squibb Company, Celon Laboratories Limited, and Cadila Pharmaceuticals Limited.
Check Discount on This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=353
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fibrosarcoma Market Assessment by Products, Drug Profile forecast for 2017-2026 here
News-ID: 964254 • Views: …
More Releases from Fact.MR
Agricultural Film Market is forecasted to reach US$ 21 billion with 5.9% CAGR by …
Fact.MR, a market research and competitive intelligence service, states that historically, the use of Agricultural Films grew at a 3.5% CAGR from 2016 to 2020, with the United States, China, India, and Japan holding a sizable portion of the global market. by 2021, the greenhouse film industry is expected to have grown to a valuation of over US$ 10 billion, largely due to price increases in agricultural films.
For More Insights…
Medical Equipment Rental Market is projected to expand at a CAGR of 5.5% to reac …
The latest industry analysis from Fact.MR, a company that offers competitive intelligence and market research, projects that the global Medical Equipment Rental Market will grow at a 5.5% CAGR and reach US$ 98 billion in size by the end of 2033.
The industry that deals with the short-term rental or lease of medical equipment to healthcare facilities, organizations, and individuals is known as the "medical equipment rental market." The goal of…
Craft Beer Market is forecasted to reach a value of US$ 174.68 Billion by 2032
The worldwide craft beer market was expected to be worth $76.3 billion in 2020 and $81.64 billion in 2021. The market will grow at a steady CAGR of 6.9% between 2022 and 2032. By the end of 2032, this market is predicted to have a global valuation of US$174.68 billion.
The surge in demand for more beer styles coupled with increase in per capita income among the target customers has triggered…
Window Blinds Market Forecasted to Achieve US$ 4.69 Billion by 2034
The global window blinds market is expected to reach $2.99 billion in 2024, growing at a 5.8% CAGR to $4.69 billion by the end of 2034.
Window blinds are adjustable window coverings made of slats or vanes, allowing for versatile control over light and privacy. They come in various materials, including wood, metal, or plastic, and can be easily adjusted to regulate sunlight and maintain privacy. Unlike heavy curtains, blinds are…
More Releases for Fibrosarcoma
Fibrosarcoma Market to Expand at a Healthy CAGR of 5.5% through 2031
Fibrosarcoma has no definite cause like other sarcomas. However, most of the sarcomas are associated with the genetic mutations. Soft tissue fibrosarcoma is among rare cancer which has no exact cause but carries various risk factors. Undergoing as radiotherapy to treat other cancer is one of the factors that is increasing the risk of fibrosarcoma.
This report works as a rich source of information for key entities such as policy makers,…
Fibrosarcoma Market: Hospital Pharmacies to Generate Significant Revenues Throug …
Undertaking radiotherapy for the treatment of malignant tumor has led to prevalence of fibrosarcoma among cancer patients. Fibrosarcoma is a rare malignant tumor that is generally treated by conducting radiation treatments and chemotherapy. As there are very few treatment procedures for fibrosarcoma, research and healthcare institutions are investing in research and development to develop effective treatment techniques. In addition, leading research institutes are focusing on developing targeted therapies that targets…
Fibrosarcoma - Pipeline Review, H1 2018 by MarketResearchReports.biz
"The Report Fibrosarcoma - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Fibrosarcoma Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fibrosarcoma - Pipeline Review, H1 2018, provides an overview of the Fibrosarcoma (Oncology) pipeline landscape.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581047
Fibrosarcoma is a malignant tumor derived from fibrous connective tissue.…
Fibrosarcoma treatment Market Estimated To Flourish By 2025
Sarcoma is referred to as a type of cancer that originates from the mesenchymal transformed cells. Fibrosarcoma is a rare malignancy, which is characterized by anaplastic undifferentiated spindle cells or proliferating immature fibroblasts in a storiform appearance. The disease arises from the fibrous tissue of bones such as the tibia, the femur, or the mandible. The tumor may be categorized based on differentiation degree into low-grade malignancy, intermediate malignancy, and…
Fibrosarcoma - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Fibrosarcoma - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fibrosarcoma - Pipeline Review, H2 2017, provides an overview of the Fibrosarcoma (Oncology) pipeline landscape.
Fibrosarcoma is a malignant tumor derived from fibrous connective tissue. Symptoms include local pain, local swelling, local warmth, dilated blood vessels pain…
Fibrosarcoma - Pipeline Insight and Therapeutic Assessment Reviewed in 2017
Market Research Hub's latest Pharmaceutical and “Healthcare disease pipeline guide Fibrosarcoma Pipeline Review”, H2 2017, provides an overview of the Fibrosarcoma (Oncology) pipeline landscape.
Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1305535
Fibrosarcoma is a malignant tumor derived from fibrous connective tissue. Symptoms include local pain, local swelling, local warmth, dilated blood vessels pain and swelling of the bone, pathological fractures, neurological and vascular changes.
Report Highlights
Market Research Hub's Pharmaceutical and Healthcare latest…
